Early and late effects of highly active antiretroviral therapy: A 2 year follow-up of antiviral-treated and antiviral-naive chronically HIV-infected patients

Mario Clerici, Elena Seminari, Franco Maggiolo, Angelo Pan, Marco Migliorino, Daria Trabattoni, Francesco Castelli, Fredy Suter, Maria Luisa Fusi, Lorenzo Minoli, Giampiero Carosi, Renato Maserati

Research output: Contribution to journalArticle

Abstract

Background: Control of HIV replication can be observed in highly active antiretroviral therapy (HAART)-treated and, occasionally, in HAART-naive patients. The immunological correlates of these situations were examined in a longitudinal study. Design: A prospective study. Immunovirological analyses in 16 chronically HIV-infected, HAART-naive patients (time 0) who started HAART. Fifteen patients (short-term HAART) were re-evaluated after 24 months (time 1). Results were compared with those of 30 patients who received HAART for more than 12 months before the study period (long-term HAART) and were analysed at the same timepoints. Fifteen patients who were antiviral therapy naive (naive) at both timepoints were also studied. Results: Over a 24-month period CD4 and CD8 cell counts and viraemia remained unchanged in naive and long-term HAART patients; CD4 cell counts increased and viraemia diminished in short-term HAART individuals. Antigen-stimulated proliferation was unmodified in naive and short-term HAART patients, but improved in long-term HAART individuals. Gp160-stimulated IL-2 and IFN-γ production was augmented in long-term HAART patients and marginally modified in other patients. IL-7 production was unmodified in naive individuals, augmented in short-term HAART patients, and diminished in long-term HAART patients. Chemokine production was similar in all patients. Naive patients showed the highest CD8 cell counts at both timepoints. Conclusion: HAART has a major impact on the outcome of HIV infection, even if functional immune modulation in HAART-treated patients is evident only after long periods of therapy. Low but detectable HIV replication in HAART-naive patients with preserved immune functions might not be associated with CD4 cell reduction, functional immune defects, or changes in viraemia.

Original languageEnglish
Pages (from-to)1767-1773
Number of pages7
JournalAIDS (London, England)
Volume16
Issue number13
DOIs
Publication statusPublished - Sep 6 2002

Fingerprint

Highly Active Antiretroviral Therapy
varespladib methyl
Antiviral Agents
HIV
Viremia
CD4 Lymphocyte Count
Interleukin-7
Chemokines

Keywords

  • Cytokines
  • HAART
  • HIV
  • IL-7
  • Immunology
  • Virology

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

Early and late effects of highly active antiretroviral therapy : A 2 year follow-up of antiviral-treated and antiviral-naive chronically HIV-infected patients. / Clerici, Mario; Seminari, Elena; Maggiolo, Franco; Pan, Angelo; Migliorino, Marco; Trabattoni, Daria; Castelli, Francesco; Suter, Fredy; Fusi, Maria Luisa; Minoli, Lorenzo; Carosi, Giampiero; Maserati, Renato.

In: AIDS (London, England), Vol. 16, No. 13, 06.09.2002, p. 1767-1773.

Research output: Contribution to journalArticle

Clerici, Mario ; Seminari, Elena ; Maggiolo, Franco ; Pan, Angelo ; Migliorino, Marco ; Trabattoni, Daria ; Castelli, Francesco ; Suter, Fredy ; Fusi, Maria Luisa ; Minoli, Lorenzo ; Carosi, Giampiero ; Maserati, Renato. / Early and late effects of highly active antiretroviral therapy : A 2 year follow-up of antiviral-treated and antiviral-naive chronically HIV-infected patients. In: AIDS (London, England). 2002 ; Vol. 16, No. 13. pp. 1767-1773.
@article{7b966ce1a2da44eaa3d428f06090a7b5,
title = "Early and late effects of highly active antiretroviral therapy: A 2 year follow-up of antiviral-treated and antiviral-naive chronically HIV-infected patients",
abstract = "Background: Control of HIV replication can be observed in highly active antiretroviral therapy (HAART)-treated and, occasionally, in HAART-naive patients. The immunological correlates of these situations were examined in a longitudinal study. Design: A prospective study. Immunovirological analyses in 16 chronically HIV-infected, HAART-naive patients (time 0) who started HAART. Fifteen patients (short-term HAART) were re-evaluated after 24 months (time 1). Results were compared with those of 30 patients who received HAART for more than 12 months before the study period (long-term HAART) and were analysed at the same timepoints. Fifteen patients who were antiviral therapy naive (naive) at both timepoints were also studied. Results: Over a 24-month period CD4 and CD8 cell counts and viraemia remained unchanged in naive and long-term HAART patients; CD4 cell counts increased and viraemia diminished in short-term HAART individuals. Antigen-stimulated proliferation was unmodified in naive and short-term HAART patients, but improved in long-term HAART individuals. Gp160-stimulated IL-2 and IFN-γ production was augmented in long-term HAART patients and marginally modified in other patients. IL-7 production was unmodified in naive individuals, augmented in short-term HAART patients, and diminished in long-term HAART patients. Chemokine production was similar in all patients. Naive patients showed the highest CD8 cell counts at both timepoints. Conclusion: HAART has a major impact on the outcome of HIV infection, even if functional immune modulation in HAART-treated patients is evident only after long periods of therapy. Low but detectable HIV replication in HAART-naive patients with preserved immune functions might not be associated with CD4 cell reduction, functional immune defects, or changes in viraemia.",
keywords = "Cytokines, HAART, HIV, IL-7, Immunology, Virology",
author = "Mario Clerici and Elena Seminari and Franco Maggiolo and Angelo Pan and Marco Migliorino and Daria Trabattoni and Francesco Castelli and Fredy Suter and Fusi, {Maria Luisa} and Lorenzo Minoli and Giampiero Carosi and Renato Maserati",
year = "2002",
month = "9",
day = "6",
doi = "10.1097/00002030-200209060-00009",
language = "English",
volume = "16",
pages = "1767--1773",
journal = "AIDS",
issn = "0269-9370",
publisher = "NLM (Medline)",
number = "13",

}

TY - JOUR

T1 - Early and late effects of highly active antiretroviral therapy

T2 - A 2 year follow-up of antiviral-treated and antiviral-naive chronically HIV-infected patients

AU - Clerici, Mario

AU - Seminari, Elena

AU - Maggiolo, Franco

AU - Pan, Angelo

AU - Migliorino, Marco

AU - Trabattoni, Daria

AU - Castelli, Francesco

AU - Suter, Fredy

AU - Fusi, Maria Luisa

AU - Minoli, Lorenzo

AU - Carosi, Giampiero

AU - Maserati, Renato

PY - 2002/9/6

Y1 - 2002/9/6

N2 - Background: Control of HIV replication can be observed in highly active antiretroviral therapy (HAART)-treated and, occasionally, in HAART-naive patients. The immunological correlates of these situations were examined in a longitudinal study. Design: A prospective study. Immunovirological analyses in 16 chronically HIV-infected, HAART-naive patients (time 0) who started HAART. Fifteen patients (short-term HAART) were re-evaluated after 24 months (time 1). Results were compared with those of 30 patients who received HAART for more than 12 months before the study period (long-term HAART) and were analysed at the same timepoints. Fifteen patients who were antiviral therapy naive (naive) at both timepoints were also studied. Results: Over a 24-month period CD4 and CD8 cell counts and viraemia remained unchanged in naive and long-term HAART patients; CD4 cell counts increased and viraemia diminished in short-term HAART individuals. Antigen-stimulated proliferation was unmodified in naive and short-term HAART patients, but improved in long-term HAART individuals. Gp160-stimulated IL-2 and IFN-γ production was augmented in long-term HAART patients and marginally modified in other patients. IL-7 production was unmodified in naive individuals, augmented in short-term HAART patients, and diminished in long-term HAART patients. Chemokine production was similar in all patients. Naive patients showed the highest CD8 cell counts at both timepoints. Conclusion: HAART has a major impact on the outcome of HIV infection, even if functional immune modulation in HAART-treated patients is evident only after long periods of therapy. Low but detectable HIV replication in HAART-naive patients with preserved immune functions might not be associated with CD4 cell reduction, functional immune defects, or changes in viraemia.

AB - Background: Control of HIV replication can be observed in highly active antiretroviral therapy (HAART)-treated and, occasionally, in HAART-naive patients. The immunological correlates of these situations were examined in a longitudinal study. Design: A prospective study. Immunovirological analyses in 16 chronically HIV-infected, HAART-naive patients (time 0) who started HAART. Fifteen patients (short-term HAART) were re-evaluated after 24 months (time 1). Results were compared with those of 30 patients who received HAART for more than 12 months before the study period (long-term HAART) and were analysed at the same timepoints. Fifteen patients who were antiviral therapy naive (naive) at both timepoints were also studied. Results: Over a 24-month period CD4 and CD8 cell counts and viraemia remained unchanged in naive and long-term HAART patients; CD4 cell counts increased and viraemia diminished in short-term HAART individuals. Antigen-stimulated proliferation was unmodified in naive and short-term HAART patients, but improved in long-term HAART individuals. Gp160-stimulated IL-2 and IFN-γ production was augmented in long-term HAART patients and marginally modified in other patients. IL-7 production was unmodified in naive individuals, augmented in short-term HAART patients, and diminished in long-term HAART patients. Chemokine production was similar in all patients. Naive patients showed the highest CD8 cell counts at both timepoints. Conclusion: HAART has a major impact on the outcome of HIV infection, even if functional immune modulation in HAART-treated patients is evident only after long periods of therapy. Low but detectable HIV replication in HAART-naive patients with preserved immune functions might not be associated with CD4 cell reduction, functional immune defects, or changes in viraemia.

KW - Cytokines

KW - HAART

KW - HIV

KW - IL-7

KW - Immunology

KW - Virology

UR - http://www.scopus.com/inward/record.url?scp=18644382965&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=18644382965&partnerID=8YFLogxK

U2 - 10.1097/00002030-200209060-00009

DO - 10.1097/00002030-200209060-00009

M3 - Article

C2 - 12218388

AN - SCOPUS:18644382965

VL - 16

SP - 1767

EP - 1773

JO - AIDS

JF - AIDS

SN - 0269-9370

IS - 13

ER -